Original article
Clinical Results of Ab Interno Trabeculotomy Using the Trabectome for Open-Angle Glaucoma: The Mayo Clinic Series in Rochester, Minnesota

https://doi.org/10.1016/j.ajo.2013.06.001Get rights and content

Purpose

To determine outcomes of ab interno trabeculotomy for treatment of open-angle glaucoma (OAG).

Design

Retrospective interventional single-surgeon, single-center case series.

Methods

Data were collected from 246 patients undergoing ab interno trabeculotomy between September 1, 2006, and December 1, 2010, with 3 months' follow-up or longer. Kaplan-Meier analysis was performed using Criteria A (postoperative intraocular pressure [IOP] ≤21 mm Hg or ≥20% reduction from preoperative IOP) and Criteria B (IOP ≤18 mm Hg and ≥20% reduction in IOP). Failure included increased glaucoma medications or subsequent surgery. Failure risk factors were identified using Cox proportional hazards ratio (HR).

Results

Of 88 cases of ab interno trabeculotomy-only and 158 cases of ab interno trabeculotomy with cataract extraction, the retention rate was 70% for 1 year and 62% for 2 years. Preoperative mean IOP was 21.6 ± 8.6 mm Hg; the number of glaucoma medications was 3.1 ± 1.1. At 24 months postoperatively, mean IOP was reduced 29% to 15.3 ± 4.6 mm Hg (P < 0.001) and the number of glaucoma medications was reduced 38% to 1.9 ± 1.3 (P < 0.001) with a success rate of 62% (95% CI, 56%–68%) using Criteria A and 22% (95% CI, 16%–29%) using Criteria B. Failure risk factors using Criteria A included primary OAG (HR 3.14, P < 0.01, 95% CI, 1.91–5.17) and past argon laser trabeculoplasty (HR 1.81, P < 0.01, 95% CI, 1.18–2.77). Using Criteria B, the HR for pseudoexfoliative glaucoma was 0.43 (P < 0.01, 95% CI 0.27–0.67). Of the cases, 66 (26.8%) required subsequent surgery on an average of 10 months (2 days to 3.2 years) after ab interno trabeculotomy.

Conclusions

For criteria involving IOP ≤18 mm Hg, the 24-month survival of ab interno trabeculotomy is low. This surgery is appropriate for patients requiring a target IOP of 21 mm Hg or above.

Section snippets

Subjects

Patients who had undergone ab interno trabeculotomy by one surgeon (A.J.S.) at the Mayo Clinic in Rochester, Minnesota, between September 1, 2006, and December 1, 2010, were eligible for this study. Patients who underwent ab interno trabeculotomy at our center typically had OAG that was refractory to medical therapy, or they had visually significant cataracts in the setting of OAG on maximal medical therapy. In a small number of cases, patients with potentially occludable angles were included

Results

During the study period, there were 286 cases (246 patients) of ab interno trabeculotomy in total, of which 40 cases (38 patients) were excluded for the following reasons: lack of consent for medical records to be used for research purposes (9 cases); resident involvement in surgery (7 cases); fewer than 3 months of postoperative follow-up at our center (22 cases); and prior ab interno trabeculotomy (2 cases). A total of 246 cases (208 patients) of ab interno trabeculotomy were included,

Discussion

Ab interno trabeculotomy using the Trabectome is a relatively new option for reducing the IOP and the number of glaucoma medications in selected patients with OAG. However, our results show that when more stringent criteria for success are used, the overall success rate of ab interno trabeculotomy can drop within 24 months after surgery to levels that may be clinically unacceptable. Despite significant lowering of mean IOP and mean number of medications postoperatively, most patients do not

Yachna Ahuja, MD, is a glaucoma fellow at the Byers Eye Institute at Stanford in Palo Alto, California. She received her medical degree at Case Western Reserve University in Cleveland, Ohio as a four-year Amici Merit Scholar. She completed a clinical research training fellowship at the National Cancer Institute in Bethesda, Maryland, after which she did her residency in ophthalmology at the Mayo Clinic in Rochester, Minnesota.

References (23)

  • R. Ritch et al.

    Why is glaucoma associated with exfoliation syndrome?

    Prog Retin Eye Res

    (2003)
  • Cited by (117)

    • Noninferiority of Microhook to Trabectome: Trabectome versus Ab Interno Microhook Trabeculotomy Comparative Study (Tram Trac Study)

      2022, Ophthalmology Glaucoma
      Citation Excerpt :

      Besides, in facilities where Trabectome surgery was performed substantially, the 1-quadrant incision was a primary option for μTLO probably because of the familiarity of surgeons with the nasal incision of the trabecular meshwork.8 In addition, concomitant cataract surgery was reported to improve the surgical success rates of both ab externo and ab interno trabeculotomy.11,25–27,31–33 As such, various confounding factors affect the surgical outcomes in trabeculotomy.

    • A Prospective Study of Intraocular Pressure Spike and Failure After Gonioscopy-Assisted Transluminal Trabeculotomy in Juvenile Open-Angle Glaucoma: A Prospective Study of GATT in JOAG

      2022, American Journal of Ophthalmology
      Citation Excerpt :

      To our knowledge, this study is the first to prospectively evaluate the angle changes using anterior segment OCT after GATT and to analyze the rate of failure and its relationship with postoperative IOP spikes in JOAG. Currently, GATT is thought to be most successful in patients with mild to moderate glaucoma, similar to other minimally invasive glaucoma operations targeted at the same pathologic site.15,16 In this study, we found significant reductions in IOP and the number of medications in patients with JOAG, demonstrating a 1-year qualified success rate of 91.4% and complete success rate of 74.3%, with 55 (78.6%) of eyes demonstrating an IOP reduction >30% and 50 (71.4%) a reduction of >40%.

    • Combination Cataract Extraction, Goniotomy, Ahmed Valve and Retrobulbar tube in a patient with bilateral Uveitic Glaucoma and Cogan's Syndrome

      2022, Journal of the National Medical Association
      Citation Excerpt :

      One study that looked at the efficacy of the OMNI device with phacoemulsification found a mean IOP reduction of about 5.6 mmHg in eyes included in the study.17 Multiple studies have shown the efficacy of goniotomy, reporting results similar to that of the OMNI device's efficaciousness.16, 18-21 Performing cataract surgery at this time helps to lower IOP while improving vision.

    View all citing articles on Scopus

    Yachna Ahuja, MD, is a glaucoma fellow at the Byers Eye Institute at Stanford in Palo Alto, California. She received her medical degree at Case Western Reserve University in Cleveland, Ohio as a four-year Amici Merit Scholar. She completed a clinical research training fellowship at the National Cancer Institute in Bethesda, Maryland, after which she did her residency in ophthalmology at the Mayo Clinic in Rochester, Minnesota.

    Arthur J. Sit, SM, MD, is an Associate Professor of Ophthalmology at the Mayo Clinic in Rochester, Minnesota. He completed his Master's degree in Mechanical Engineering at the Massachusetts Institute of Technology, his MD and residency at the University of Toronto, and a glaucoma fellowship at the University of California San Diego. He currently serves as Chair of the American Glaucoma Society Research Committee. He is a Research to Prevent Blindness Special Scholar.

    View full text